Pharmaceutical company Merck has revealed that gefapixant, its experimental drug designed to address chronic cough, still has a ways to go before hitting the US…
Mild cases of COVID-19 that don't result in obvious "long COVID" symptoms may still trigger memory and attention problems, according to a new study from…
Many have heard of immunosuppressive drugs, which are a type of medication that suppresses the immune system, but lesser-known are immunostimulatory drugs, which stimulate the…
The organ donor crisis has long inspired the medical fraternity to look for feasible donors from other species. This week, doctors at the University of…
Pfizer has announced its Omicron COVID-19 booster is already in production as the variant has led to a massive increase in cases worldwide, accounting for…
The Food and Drug Administration (FDA) has taken multiple actions to expand vaccine availability for children in an effort to combat the COVID-19 virus, including…
Pfizer's Paxlovid is the first oral COVID-19 treatment to get FDA authorization for use in the US. The health agency announced its decision today, noting…
Moderna has published the latest data on its COVID-19 vaccine, reporting a drastic increase in antibody levels against the SARS-CoV-2 omicron variant compared to the…